WHAT'S KNOWN ON THIS SUBJECT: A growing number of epidemiologic studies suggest that individuals with lower vitamin D levels are at higher risk of acute respiratory infection. Randomized controlled trials are needed to determine if vitamin D supplementation would decrease this risk. METHODS: By using cluster randomization, classrooms of 744 Mongolian schoolchildren were randomly assigned to different treatments in winter (January-March). This analysis focused on a subset of 247 children who were assigned to daily ingestion of unfortified regular milk (control; n = 104) or milk fortified with 300 IU of vitamin D 3 (n = 143). This comparison was double-blinded. The primary outcome was the number of parent-reported ARIs over the past 3 months.
Situated in Central Asia, Mongolia is a country where UV-B radiation in winter is inadequate to induce cutaneous vitamin D synthesis. 1 Moreover, cold temperatures throughout much of the year cause Mongolians to limit direct exposure of their skin to sunlight in all but summer. These factors, combined with the absence of vitamin D fortification of food and the limited availability of vitamin D supplements, have led to a high risk for vitamin D deficiency among Mongolians, particularly during winter. 2 Although vitamin D is known to play a major role in calcium metabolism and bone health, observational studies suggest that low levels may contribute to risk of many different diseases, including acute respiratory infections (ARIs). 3 For example, Camargo et al 4 recently reported an inverse association between cord blood levels of 25-hydroxyvitamin D (25[OH]D) and risk of ARI in the first 3 months of life. In 2010, Urashima et al 5 reported the first randomized controlled trial (RCT) on vitamin D and ARIs in children; the authors found use of a vitamin D supplement lowered risk of influenza A (primary outcome) but had no significant effect on influenza B. These seemingly discordant findings contributed to the 2011 conclusion of the Institute of Medicine that the effect of vitamin D status on ARI risk was unclear and additional RCTs are needed. 6 To further examine the effect of vitamin D status on risk of childhood ARI, we analyzed data from a recently completed RCT involving 744 Mongolian children, a population with low levels of 25(OH)D in winter. 7 Although the trial included 6 arms, we focused on 2 arms with double-blinding: children assigned to daily intake of regular milk versus vitamin D-fortified milk (Fig 1) . We hypothesized that vitamin D supplementation of Mongolian children would lower the risk of ARIs.
METHODS

Study Design and Subjects
The Blue Sky Study was conducted in Ulaanbaatar, Mongolia (latitude 48°N) in association with the Health Sciences University of Mongolia, the Mongolian Ministries of Health and Education, Harvard University, and Boston University. This RCT included 744 Mongolian children from 21 third-and fourth-grade classrooms (96% of 779 invited children). The schools were selected for their size, proximity, and comparable sociodemographic profiles. The primary aims of the trial were to test the effects of vitamin D-fortified beverages or vitamin D pills on serum 25(OH)D levels, somatotropic hormones, and growth and development among prepubertal children; these aims determined the sample size. The primary results of the Blue Sky Study have been published elsewhere. 7 Briefly, delivery of 300 IU daily by using fortified beverages or pill supplements improved 25(OH)D concentrations but failed to raise levels above 20 ng/mL (50 nmol/ L) uniformly. There were no significant adverse events.
Vitamin D Supplementation
The Blue Sky Study examined 5 approaches to improve the vitamin D status of Mongolian schoolchildren: (1) 300 IU of vitamin D 3 daily in Mongolian milk (n = 143); (2) 300 IU of vitamin D 3 daily in US milk (n = 143); (3) 300 IU of vitamin D 3 daily in a milk substitute (n = 147); (4) 300 IU of vitamin D 3 in a daily pill (n = 112); and (5) a total of 13 700 IU of vitamin D 3 in pills given over the first 7 days of study (n = 95). The comparison group for these vitamin D interventions was a sixth randomly assigned group given unfortified regular Mongolian milk daily (control; n = 104); all of the children in the control group were given vitamin D supplements after the study ended. Every group, except for the control group, received ∼13 700 IU of vitamin D during the 7-week study period (late January to mid-March 2009). Randomization was based on a random number generator, with allocation concealment and off-site assignment of classrooms to a specific intervention. 7 For the current analysis, to ensure that the group assignment was double-blinded and that other differences were minimized, we focused on 2 specific groups: the children receiving unfortified regular Mongolian milk (control group) versus those receiving vitamin D-fortified Mongolian milk (vitamin D group). The added vitamin D 3 was odorless, colorless, and tasteless so children, teachers, and researchers were unable to tell whether children in any particular classroom were receiving supplementation. This comparison was determined a priori. In a secondary analysis, we examined results in the other vitamin D interventions versus the control group.
25(OH)D Level
A blood sample was taken from each child at baseline and at follow-up. This blood was used to determine the serum 25(OH)D concentration by using liquid chromatography-tandem mass spectrometry through a turbulent flow liquid chromatography system (Cohesive Technologies, Franklin, MA) followed by traditional laminar flow chromatography. The analysis was performed by using a TSQ Quantum Ultra triple massspectrometer (Thermo Finnigan Corporation, San Jose, CA). 8 The intra-assay coefficient of variation was 18.7% in this sample with very low 25(OH)D concentrations; in populations with a wider range of 25(OH)D concentrations, the intra-assay coefficient of variation is 9%. For 8 (3%) of the 247 children in the primary comparison, either the 25(OH)D value at baseline or at follow-up was unavailable.
Outcomes
The primary outcome for this analysis, collected by using a survey at completion of the study, was the parentreported number of ARIs that occurred during the preceding 3 months. ARIs were ascertained by using the following question: "Over the past 3 months, how many chest infections or 'colds' has your child had-counting only those infections that lasted for at least 24 hours with symptoms?" The response categories were counts from "none" to "six or more." Among the 247 children in the primary comparison, outcome data were missing for only 3 children (1 lost to follow-up and 2 discontinued the intervention due to changing schools).
Assessment of Other Covariates
Trained study assistants helped the children and their parents/guardians to complete questionnaires at the enrollment and follow-up visits. In addition to sociodemographic characteristics, aspects of respiratory health were assessed. The wheeze question was taken from the International Study of Asthma and Allergies in Childhood 9 : "Has your child had wheezing or whistling in the chest at any time in the past?"
Data Analysis
All analyses were performed by using Stata version 11.1 (StataCorp LP, College Station, TX). Equality between the 2 groups (regular versus fortified milk) was tested for each of the baseline characteristics by using generalized estimation equations to adjust for intraclass correlation. Depending on the nature of the baseline characteristic, logistic, negative binomial, and linear regression analysis was used.
To test the association between vitamin D supplementation and the number of ARIs in the past 3 months, unadjusted and adjusted random-intercept negative binomial regression were used in an intention-to-treat analysis. We decided a priori to include age, gender, and baseline "ever wheeze" history as covariates in our multivariable analysis. The confounding effect of covariates was assessed by examining the association of vitamin D supplementation with ARI before and after adding the covariates as fixed effects to the model. Moreover, because classrooms (and not individual children) were assigned the different treatment groups, our analyses assume correlation between the children of each class; random effects for each classroom were entered to account for this intraclass correlation. The models were compared by using deviance statistics.
To examine if the effect of vitamin D supplementation on ARI risk varied according to baseline 25(OH)D status, children were stratified according to their median baseline 25(OH)D level, and the multivariable regression analysis was repeated in the 2 subgroups. We formally tested for interaction with a multiplicative term. In a secondary analysis, the primary analysis was repeated but focused on the 2 major vitamin D interventions (vitamin D in beverages or in pills) versus the unfortified milk control. Model results are reported as rate ratios (RRs) with 95% confidence intervals (CIs). A 2-tailed P , .05 was considered statistically significant. Table 1 displays the characteristics of children in the 2 randomly assigned groups: those assigned to receive regular Mongolian milk (control) versus those assigned to receive vitamin Dfortified Mongolian milk. As expected, there were no significant differences between the randomly assigned groups at baseline. Specifically, the median serum 25(OH)D concentrations of children in the control and intervention groups were nearly identical (6.8 vs 7.0 ng/mL; P = .58). In January, 99% of these apparently healthy Mongolian schoolchildren were vitamin D deficient (using a definition of ,20 ng/mL). At follow-up ∼7 weeks later, the 2 groups differed significantly in their median serum 25(OH) D level (7.2 vs 18.9 ng/mL; P , .001). Even in the intervention group, however, most children continued to have serum 25(OH)D levels ,20 ng/mL. Figure 2 shows the parent-reported number of ARIs at follow-up in both groups. Compared with children in the control group, children receiving vitamin D-fortified milk were less likely to report 1 or more ARIs over the winter. These frequencies suggest an inverse association between vitamin D supplementation and risk of ARI. Indeed, the unadjusted regression model in ARTICLE Table 2 In a secondary analysis, children were analyzed from all arms with follow-up data for the parent-reported number of ARIs over the past 3 months (n = 713). The same statistical analyses were performed as done for our primary analysis, and consistent results were found. For example, in the randomintercept negative binomial model adjusted for age, gender, and wheezing history, the RR for ARI was lower for Although vitamin D is widely recognized for its importance in calcium metabolism and bone health, researchers worldwide have focused for several years on a growing number of possible, noncalcemic health effects. 3 One of the more promising areas is the relation between vitamin D status and respiratory infections. In addition to both historical 10 and contemporary 11 work on the potential benefits of sunlight and vitamin D supplementation on tuberculosis, there is growing appreciation that low, but nonrachitic, levels of vitamin D may also affect risk of other respiratory infections. 12, 13 Indeed, several observational studies suggest that better vitamin D status is associated with lower risk of infectionrelated phenomena such as childhood wheezing. 14, 15 Recent studies in Pediatrics have shown that cord blood levels of 25(OH)D have a strong inverse To reach this 20-ng/mL threshold requires supplement doses .300 IU daily. At the time the trial was designed, the Institute of Medicine recommended 200 IU daily for all individuals from birth to age 50 years. 21 The 2011 Institute of Medicine report has since increased the recommendation to 400 IU daily for children. 6 Although this higher dose is certainly an improvement, we suspect that even 400 IU daily will fall short for many children with vitamin D deficiency.
RESULTS
Other groups, such as the Canadian Paediatric Society, 22 recommend 1000 IU daily for children, and we believe that this higher dose is more likely to achieve adequate 25(OH)D levels for almost all children without pushing them to a potentially toxic level. In addition to traditional concerns about hypercalcemia, which begin at 25(OH)D levels $100 ng/mL, 23 there are emerging concerns about increased atopy risk with less dramatically elevated levels, such as cord blood levels .40 ng/mL (.100 nmol/L). 24 Should the latter 
